Hospital
Trinity Medical Center
Trinity Medical Center was paid $5.23M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99284, emergency room visit (serious) — 42% of everything it billed.
33Billing provider infoTRINITY MEDICAL CENTER
BETTENDORF, IA 52722
BETTENDORF, IA 52722
33aNPI1124110820assigned 09/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.23M
24GClaims118,663
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Iowa
Rank by total paid#16 of 29
Median peer was paid$6.37M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,518 | $927K | |
| 2019 | 23,019 | $1.02M | |
| 2020 | 15,114 | $634K | |
| 2021 | 16,588 | $734K | |
| 2022 | 17,584 | $860K | |
| 2023 | 18,446 | $826K | |
| 2024incomplete | 6,394 | $230K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 42% | 9,448 | 9,016 | $2.22M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 8,501 | 8,095 | $1.27M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.7% | 5,340 | 4,845 | $405K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7.5% | 37,204 | 35,638 | $394K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.9% | 647 | 611 | $204K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 1,548 | 1,520 | $138K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 790 | 758 | $103K |
| 59025 | Fetal non-stress test | 1.5% | 651 | 357 | $79K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.4% | 725 | 676 | $72K |
| 62323 | <1% | 133 | 128 | $52K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 813 | 782 | $46K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,309 | 14,128 | $36K |
57 more codes
| 20552 | <1% | 134 | $24K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 444 | $22K |
| 80061 | Lipid panel | <1% | 1,703 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,452 | $17K |
| 20610 | <1% | 106 | $17K | |
| 80053 | Comprehensive metabolic panel | <1% | 7,965 | $16K |
| 97597 | <1% | 138 | $13K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,016 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,678 | $12K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 119 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 215 | $9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 478 | $7K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 16 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 800 | $5K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,488 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 898 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 45 | $2K |
| 86900 | <1% | 28 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 123 | $2K |
| 80076 | <1% | 352 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 111 | $2K |
| 85027 | <1% | 746 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 31 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 180 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $1K |
| 86762 | <1% | 68 | $814.74 | |
| 87340 | <1% | 80 | $569.37 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 163 | $558.75 |
| 86593 | <1% | 269 | $534.24 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 54 | $443.00 |
| 86803 | <1% | 29 | $292.57 | |
| 84702 | <1% | 17 | $264.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 128 | $179.96 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $117.15 |
| 83690 | <1% | 710 | $112.86 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 14 | $100.75 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 15 | $73.89 |
| 81003 | <1% | 825 | $63.50 | |
| 83735 | <1% | 261 | $38.22 | |
| 81025 | <1% | 455 | $32.72 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,087 | $31.44 |
| 84484 | <1% | 173 | $27.57 | |
| 81001 | <1% | 112 | $7.13 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 43 | $6.90 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 26 | $0.00 |
| 76942 | 0% | 27 | $0.00 | |
| 87081 | 0% | 206 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 71 | $0.00 |
| 87430 | 0% | 272 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 35 | $0.00 |
| 86901 | 0% | 28 | $0.00 | |
| 83605 | 0% | 13 | $0.00 | |
| 87807 | 0% | 17 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 13 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 12 | $0.00 |
| 86850 | 0% | 28 | $0.00 | |
| 86140 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORROW, SHAWN (PRESIDENT)
Parent organizationTRINITY MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Unity Healthcare | Muscatine, IA | $12.67M |
| Unity Healthcare | Muscatine, IA | $8.70M |
| Unity Healthcare | Muscatine, IA | $5.14M |
| Unity Healthcare | Muscatine, IA | $3.79M |
| Unity Healthcare | Muscatine, IA | $3.78M |
| Trinity Medical Center | Rock Island, IL | $2.67M |
| Unity Healthcare | Wilton, IA | $1.57M |
| Unity Healthcare | Muscatine, IA | $155K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.